CLINICAL_TRIALS
trial_result
· 2010-05-18
Clinical Trial Update: Study Evaluating The Efficacy Of Varenicline In Cessation Of Oral Smokeless Tobacco Use [Phase 4]
Summary
Pfizer conducted a Phase 4 trial to evaluate the efficacy of varenicline for cessation of oral smokeless tobacco use; results were posted in 2010.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Tobacco Use Cessation | Phase 4 | Status: COMPLETED | Results posted: 2010-05-18